Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction

In this interview, R. Corey O'Connor, MD, discusses the recent Neurourology and Urodynamics paper, “Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction," for which he served as a study author. O'Connor is associate professor of urology at the Medical College of Wisconsin, Milwaukee.

More videos:

How do OAB patient education materials measure up?​

Disposable ureteroscope reduces costs of care​

Gender disparity seen with renal cell carcinoma management​